In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zimmer Biomet Holdings, Inc.

http://www.zimmerbiomet.com/

Latest From Zimmer Biomet Holdings, Inc.

Trials In Focus: The Challenges Of Running Cancer Trials In Community Setting

Research shows bringing trials to community oncology centers remains a daunting task, but Verily and OneOncology aim to help with new clinical trial management software. In other trial news, MindBio’s LSD goes into Phase II; Erasca starts tumor agnostic program; the Project to Accelerate New Treatments for Tuberculosis launched an international study investigating new combinations; and more.

Clinical Trials Cancer

Tornos Ascends To Zimmer Biomet CEO As Hanson Leaves For 3M Spinoff

Ivan Tornos will shift from COO to CEO of Zimmer Biomet now that former CEO Bryan Hanson has accepted the CEO job at 3M’s health care spinoff.

Executive Changes Leadership

Finance Watch: UroGen Accesses Cash After Phase III Bladder Cancer Success

Public Company Edition: UroGen raised $120m in a private placement of ordinary shares. Also, Verrica entered into a debt financing for up to $125m upon approval of Ycanth for molluscum contagiosum and job cuts were announced by Homology, Mersana, Infinity and others.

Financing Restructuring

Orthopedics Corner: Catalyst Looks To Clinical Data To Distinguish Its Shoulder Arthroplasty Technology

Orthopedics Corner is a new series highlighting new developments in spine and orthopedics technology you may have missed. Catalyst OrthoScience CEO Carl O’Connell, along with surgeon and researcher Matthew Budge, talked to Medtech Insight about Catalyst’s innovation in shoulder arthroplasty.

Clinical Trials Orthopedics
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
      • Surgical Sealants
  • Other Names / Subsidiaries
    • Abbot Spine
    • Biomet, Inc.
    • Arthrotek, Inc.
    • Biomet Biologics, Inc.
    • Cayenne Medical, Inc.
    • CD Diagnostics
    • Clinical Graphics, B.V.
    • Dornoch Medical Systems
    • Etex corporation
    • Implex Corp.
    • Knee Creations LLC
    • LDR Holding Corporation
    • NORMED Medizin-Technik GmbH
    • Quantic Biomedical
    • Ortho Transmission, LLC
    • Zimmer Holdings, Inc.
    • A&E Medical Corp.
UsernamePublicRestriction

Register